Hip Fracture Risk in Patients With a Diagnosis of Pernicious Anemia
Authors:
Open Access
- 1 April 2010
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 138 (4) , 1330-1337
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (K08 DK062978)
- University of Pennsylvania
- AstraZeneca
- GlaxoSmithKline
- National Institutes of Health
This publication has 35 references indexed in Scilit:
- Use of proton pump inhibitors and risk of osteoporosis-related fracturesCanadian Medical Association Journal, 2008
- Plasma B Vitamins, Homocysteine, and Their Relation with Bone Loss and Hip Fracture in Elderly Men and WomenThe Journal of Clinical Endocrinology & Metabolism, 2008
- RETRACTED: Effect of Folate and Mecobalamin on Hip Fractures in Patients With StrokeJAMA, 2005
- Low Plasma Vitamin B12 Is Associated With Lower BMD: The Framingham Osteoporosis StudyJournal of Bone and Mineral Research, 2005
- Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans.Journal of the American College of Nutrition, 1995
- Effect of hypochlorhydria due to omeprazole treatment or atrophic gastritis on protein-bound vitamin B12 absorption.Journal of the American College of Nutrition, 1994
- Effect of omeprazole, an inhibitor of H+, K+-ATPase, on bone resorption in humansCalcified Tissue International, 1993
- Increased fracture risk in hypercalcemia: Bone mineral content measured in hyperparathyroidismActa Orthopaedica, 1989
- Cobalamin and Osteoblast-Specific ProteinsNew England Journal of Medicine, 1988
- Calcium Absorption and AchlorhydriaNew England Journal of Medicine, 1985